Guardant Health, Inc.
GH
$161.99
$9.646.33%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 44.33% | 48.26% | 39.37% | 38.50% | 30.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 44.33% | 48.26% | 39.37% | 38.50% | 30.95% |
| Cost of Revenue | 42.79% | 40.41% | 28.22% | 25.64% | 12.13% |
| Gross Profit | 45.16% | 52.81% | 46.33% | 46.69% | 43.95% |
| SG&A Expenses | 47.75% | 50.59% | 30.57% | 23.08% | 39.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.90% | 34.71% | 22.72% | 18.03% | 21.88% |
| Operating Income | -20.66% | -9.77% | 4.00% | 15.48% | -5.85% |
| Income Before Tax | -20.12% | -17.74% | -18.07% | 14.05% | 2.57% |
| Income Tax Expenses | 386.84% | 28.28% | -341.20% | 353.33% | -71.43% |
| Earnings from Continuing Operations | -20.26% | -17.78% | -15.75% | 13.95% | 2.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.26% | -17.78% | -15.75% | 13.95% | 2.66% |
| EBIT | -20.66% | -9.77% | 4.00% | 15.48% | -5.85% |
| EBITDA | -23.32% | -11.56% | 4.01% | 15.91% | -7.19% |
| EPS Basic | -12.34% | -11.14% | -11.34% | 15.17% | 3.96% |
| Normalized Basic EPS | -11.54% | -2.25% | 0.68% | 14.13% | -13.38% |
| EPS Diluted | -12.34% | -11.14% | -11.34% | 15.17% | 3.96% |
| Normalized Diluted EPS | -11.54% | -2.25% | 0.68% | 14.13% | -13.38% |
| Average Basic Shares Outstanding | 7.05% | 5.98% | 3.96% | 1.43% | 1.36% |
| Average Diluted Shares Outstanding | 7.05% | 5.98% | 3.96% | 1.43% | 1.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |